Fidaxomicin "Chaser" Regimen Following Vancomycin for Patients With Multiple Clostridium difficile Recurrences

被引：32
|
作者：
Johnson, Stuart [1 ,2 ]
Gerding, Dale N. [1 ,2 ]
机构：
[1] Hines Vet Affairs Hosp, Chicago, IL USA
[2] Loyola Univ Chicago, Stritch Sch Med, Maywood, IL USA
来源：
CLINICAL INFECTIOUS DISEASES | 2013年 / 56卷 / 02期
关键词：
D O I：
10.1093/cid/cis833
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：309 / U167
页数：2
相关论文
共 50 条
  • [31] Randomized Clinical Trial in Clostridium difficile Infection Confirms Superiority of Fidaxomicin Over Vancomycin
    Johnson, Stuart
    Crook, Derrick W.
    Cornely, Oliver A.
    High, Kevin P.
    Miller, Mark
    Gorbach, Sherwood L.
    GASTROENTEROLOGY, 2010, 139 (01) : E17 - E17
  • [32] Fidaxomicin versus oral vancomycin for severe Clostridium difficile infection: a retrospective cohort study
    Gentry, C. A.
    Nguyen, P. K.
    Thind, S.
    Kurdgelashvili, G.
    Skrepnek, G. H.
    Williams, R. J., II
    CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (08) : 987 - 993
  • [33] Reduced Acquisition and Overgrowth of Vancomycin-Resistant Enterococci and Candida Species in Patients Treated With Fidaxomicin Versus Vancomycin for Clostridium difficile Infection
    Nerandzic, Michelle M.
    Mullane, Kathleen
    Miller, Mark A.
    Babakhani, Farah
    Donskey, Curtis J.
    CLINICAL INFECTIOUS DISEASES, 2012, 55 : S121 - S126
  • [34] Recurrences in Clostridium difficile infections in cancer patients
    Garcia-Lozano, Tomas
    Aznar-Oroval, Eduardo
    Martin-Utrilla, Salvador
    MEDICINA CLINICA, 2016, 147 (09): : 417 - 418
  • [35] Fidaxomicin: A Review of Its Use in Patients with Clostridium difficile Infection
    Scott, Lesley J.
    DRUGS, 2013, 73 (15) : 1733 - 1747
  • [36] Fidaxomicin Therapy in Critically Ill Patients with Clostridium difficile Infection
    Penziner, Samuel
    Dubrovskaya, Yanina
    Press, Robert
    Safdar, Amar
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (03) : 1781 - 1786
  • [37] Fidaxomicin: A Review of Its Use in Patients with Clostridium difficile Infection
    Lesley J. Scott
    Drugs, 2013, 73 : 1733 - 1747
  • [38] In vitro selection, via serial passage, of Clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin
    Leeds, Jennifer A.
    Sachdeva, Meena
    Mullin, Steve
    Barnes, S. Whitney
    Ruzin, Alexey
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (01) : 41 - 44
  • [39] Efficacy of fidaxomicin versus vancomycin in the treatment of Clostridium difficile infection: A systematic meta-analysis
    Zhao, Zihan
    Wu, Yarui
    Geng, Xuhua
    Yuan, Congrui
    Fu, Yi
    Yang, Guibin
    MEDICINE, 2024, 103 (32)
  • [40] Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France
    Watt, Maureen
    Dinh, Aur Elien
    Le Monnier, Alban
    Tilleul, Patrick
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (07) : 678 - 686
12345